Ontology highlight
ABSTRACT:
PROVIDER: EGAD00001003387 | EGA |
REPOSITORIES: EGA
Acta neuropathologica 20170621 5
Molecular classification of cancer has entered clinical routine to inform diagnosis, prognosis, and treatment decisions. At the same time, new tumor entities have been identified that cannot be defined histologically. For central nervous system tumors, the current World Health Organization classification explicitly demands molecular testing, e.g., for 1p/19q-codeletion or IDH mutations, to make an integrated histomolecular diagnosis. However, a plethora of sophisticated technologies is currently ...[more]